The trajectory of amyloid plaque buildup—clumps of abnormal proteins in the brain linked to Alzheimer's disease—may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total ...
Jul 15, 2013
0
0
When Georgetown University neurologist R. Scott Turner, MD, PhD, began enrolling people with mild to moderate Alzheimer's disease into a nationwide study last year, he expected to find only a handful of participants with ...
Jul 14, 2013
1
0
The lipidation states (or modifications) in certain proteins in the brain that are related to the development of Alzheimer disease appear to differ depending on genotype and cognitive diseases, and levels of these protein ...
Jun 17, 2013
1
0
Scientists at the University of Liverpool and Callaghan Innovation in New Zealand have developed a new chemical approach to help harness the natural ability of complex sugars to treat Alzheimer's disease.
May 29, 2013
0
0
The more that we understand the brain, the more complex it becomes. The same can be said about the genetics and neurobiology of psychiatric disorders. For "Mendelian" disorders, like Huntington disease, mutation of a single ...
Aug 20, 2012
0
0
(Medical Xpress) -- A team of University of Alberta researchers has identified a new class of compounds that inhibit the spread of malfunctioning proteins in the brain that cause lethal neurodegenerative diseases in humans ...
Jul 20, 2012
0
0
A new type of anti-epilepsy medication that selectively targets proteins in the brain that control excitability may significantly reduce seizure frequency in people whose recurrent seizures have been resistant to even the ...
Apr 18, 2012
0
0
(Medical Xpress) -- A researcher at the University of Sydney has discovered how the increasingly common street drug mephedrone affects the brain, helping to explain why it is potentially such an addictive substance.
Oct 31, 2011
0
0
Neurodegenerative diseases such as Alzheimer's or Parkinson's are characterised by the loss of nerve cells and the deposition of proteins in the brain tissue. A group of researchers led by Gabor G. Kovacs from the Clinical ...
Sep 24, 2012
0
0
The Huntington Study Group (HSG), under the leadership of Ray Dorsey, M.D. with Johns Hopkins Medical and Diana Rosas, M.D. with Massachusetts General Hospital, is conducting a clinical trial in Huntington's disease (HD) ...
Jun 7, 2012
0
0
